CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Leerink Partners Adjusts PT on Regeneron Pharmaceuticals to $824 From $641, Maintains Market Perform Rating

Positive
AI Analysis

Summary

Leerink Partners raised its price target on Regeneron Pharmaceuticals from $641 to $824 while maintaining a Market Perform rating.

Importance:2/10
Sentiment:
0.30
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 17, 2026 10:29 AM

Read Original